In this mega-episode our good friend Nick Gastevich joins us for the Q3 2021 quarterly review of Cresco, Curaleaf, Trulieve, Green Thumb, and Verano (in that order).
We do a deep dive into profitability, cash flow, brands, valuation and how we see the strengths and weaknesses of each company.
We discuss how well positioned each of these companies is for the current phase of our industry and for the future post-uplisting.
Thanks to Nick for another great and extensive review
Connect with Nick:
Twitter - https://twitter.com/CannaVestments
Family Office Website - https://www.vginvests.com/
Weitere Episoden von „Cannabis Investing Network“
#128 - 2022 Political Outlook for Cannabis Investing (ft. Jason aka CMDR1305)
1:05:04In this episode we are delighted to bring back our unofficial political correspondent, Jason. Jason has extensive experience working on the ‘Hill’. He was a member of 2 lobbying groups that advocated for safe and fair-trade issues and economic investment in American cities. As well, he worked for an appropriations chairman who focused on financial services and trade issues. Jason recently wrote a detailed post on reddit titled ‘Understanding Washington: 2022 The Year Ahead’. The post is well written with one of the main themes being: We must see the whole board and understand the position that our legislative agenda fits into the broader picture. This is an important perspective when considering the impact politics plays in Cannabis. We discuss this these along with the following topics: What events occurred that led to the removal of SAFE from the NDAA Money in the politics and where to look How the political catalyst landscape looks for 2022 What, if anything, we can predict about the years beyond this November’s election. The 3 Political Tests you should do to prevent getting caught up in the hype: (1) Political Test: Democratic Leadership is comfortable with a vote (2) Practical Test: There are a majority of votes in Congress (3) Bi-Partisan Test: there are votes from both sides of the aisle. Links: https://www.opensecrets.org/ Jason's Article - Understanding Washington: 2022 The Year Ahead (Click here for the article). As always, we hope you enjoy this episode.
#127 - Nothing Has Changed - Mid-Jan 2022 Market Update
1:02:24In this 2022 Market Update we discuss the theme that "nothing has changed" since late last year and why that is both positive and negative for the cannabis industry. In particular we discuss macro factors such as raising interest rates and how that sets up a difficult investing environment for 2022. We also discuss industry specific issues and give some predictions for how they may play out. Read JP's outlook for SAFE banking - https://www.reddit.com/r/weedstocks/comments/s2cw14/understanding_washington_2022_the_year_ahead/
#126 - Building Cresco into the Industry's Partner of Choice (ft. Greg Butler, CCO of Cresco Labs)
1:24:28In this episode of our executive series we are joined by Greg Butler of Cresco Labs. Greg is Cresco's Chief Commercial Officer and has a wide ranging background including pharma, private equity and alcohol. In this interview we discuss: - Greg's Origins: How he got started in cannabis and why he chose Cresco Labs - Alcohol vs Cannabis: how the industries are different and how they are similar - Competitive Threat: How Big Beer is tracking the cannabis industry - Industry Evolution: how cannabis is changing as it gets more competitive - Building a Cannabis Brand: what it means, what matters and what's changing - Financials: What will drive growth ahead for Cresco - Being the "Partner of Choice": How Cresco is positioning itself for the future of the industry - Investment and Acquisitions: What big CPG will look for when it comes time to partner with an MSO Thank you to Greg for joining us for this interview!
#125 - Our Predictions for 2022 for Cannabis Stocks
56:13Welcome to 2022! As we ring in the new year we look forward and shares some of our predictions of what is to come this year. We discuss upcoming catalysts to get excited about, headwinds to be cautious about and discuss potential wild cards that could upend the market. If 2021 taught us anything it was that "Nobody Knows" and "Expect Volatility Ahead". PS - as we start a new year we are looking to hear your suggestions for what topics you'd like to hear about! Please email us your thoughts
#124 - What Happened in 2021? Cannabis Investing Year in Review
1:10:54Recapping the rollercoaster of the year that was 2021. Cannabis investors were hoping 2021 would be “The Chosen Year” with potential for significant federal change in the US. Instead we got whiplash and a lesson in humility. In this episode we rewind to the start of the year and discuss how key events played out. The end of the year is a great time to do some sober reflection on what we got right, what we got wrong and what lessons we can take to (hopefully) improve our game in the future. Some Key Topics: - Nobody Knows: the importance of humility and staying nimble - Everyone is Retail: how price action drives investor mentality - The Quiet Role of Short Sellers and their impact on cannabis - Increased Competition across key markets - SAFE Banking and betting on federal change We also discuss how the industry has evolved in 2021 and how we are thinking about our investments heading into next year. Thank you to everyone for listening and sending in great questions! We will see you all in 2022
#123 - Understanding the New Challenges of the California market (ft. Hirsh Jain of Ananda Strategy)
46:14In this episode we are joined by special guest Hirsh Jain. Hirsh is the founder of Ananda Strategy, a consultancy that works with many of California's leading cannabis brands and retailers and has helped its clients operationalize some of the most successful cannabis facilities in the state. We unpack what’s changed since Hirsh’s last appearance. We address the elephant in the room which is the carnage that’s happening to California operators and why the top MSO’s have shifted their posture to a wait and see strategy vs looking to establish a footprint in the golden state. Although there is no optimistic sheen to put on California, there are certain steps the companies and municipalities are taking to defend the industry as well as attract investments. During the second half of the episode, we look at what new states could learn from California to make their regulated cannabis roll out more efficient. As always, if you have any questions for our guest Hirsh, please reach out to him at [email protected] or any questions for us please email us at [email protected] Connect with Hirsh: LinkedIn - https://www.linkedin.com/in/hirsh-jain-b896b080/ Ananda Strategy - http://anandastrategy.com/
#122 - Investing in Cannabis through Sale-Leasebacks (ft. Jarrett Annenberg of Newlake Capital Partners)
1:02:35In this episode we are joined by Jarrett Annenberg of Newlake Capital Partners. NLCP is a new OTC listed public cannabis REIT who owns dispensaries and cultivation facilities across the US. Their largest tenants include Curaleaf, Cresco, Trulieve, Columbia Care and other single and multi-state operators. We touch on a wide variety of topics including: - Why a delayed SAFE banking will help Newlake grow its portfolio - History repeating itself: how expectations of SAFE in 2019 are similar to 2021 - The $3B capital opportunity and where Sale-Leaseback fits into the equation - Origins of Newlake: how the company got started by raising $90M in 2019 - Scaling up by merging with Green Acreage REIT - How NLCP raised $100M to go public in a soft equity market - "A Safer Way to Play Cannabis" - why larger investors liked cannabis REITs - Why investors should be excited about NLCP and its opportunity for capital appreciation Thanks to Jarrett for joining us! Jarrett on LinkedIn - https://www.linkedin.com/in/jarrett-annenberg-8584474/ Newlake Investor Deck - https://ir.newlake.com/company-information/presentations
#121 - Taking Advantage of Volatility in Cannabis Investing (ft. Alan Brochstein of 420investor)
1:32:30In this episode we are joined by Alan "The Maven" Brochstein. Alan is an extremely experienced cannabis analyst who has been covering the sector since 2014. He is co-founder of New Cannabis Ventures and founder of 420investor. In this wide ranging conversation we discuss many different topics including: - State of the market: how AB sees the cannabis stock action compared to previous years - Cyclicality of Cannabis Stocks: How the pendulum swings to the extremes - Staying flexible: the importance of combining trading and investing mentality - Altria & Cronos: Why Alan thought (and still thinks) Altria should buy Cronos - Interesting opportunities in the market right now, especially with newer issues Thanks as always to Alan for joining us to share his insights Connect with Alan: Twitter - https://twitter.com/Invest420 420investor - https://marketfy.com/product/420investor/
#120 - Q3 2021 Financial Review of the Big 5 MSOs (ft. Nick Gastevich aka CannaVestments)
2:19:46In this mega-episode our good friend Nick Gastevich joins us for the Q3 2021 quarterly review of Cresco, Curaleaf, Trulieve, Green Thumb, and Verano (in that order). We do a deep dive into profitability, cash flow, brands, valuation and how we see the strengths and weaknesses of each company. We discuss how well positioned each of these companies is for the current phase of our industry and for the future post-uplisting. Thanks to Nick for another great and extensive review Connect with Nick: Twitter - https://twitter.com/CannaVestments LinkedIn - https://www.linkedin.com/in/nicholas-gastevich-75841346/ Family Office Website - https://www.vginvests.com/
#119 - Positioning Your Cannabis Portfolio for Ups & Downs
1:02:51What a difference 2 weeks makes! In this episode we discuss a few key themes around the biggest issues we are seeing in today's market 1) Narratives vs Reality - how the divergence creates opportunity for investors 2) Nancy Mace Legalization bill - what this really means and the effect its having on the market 3) $MSOS huge cash inflows and how we expect this to impact the cannabis stock market short term 4) Strategy - ideas on position your portfolio to play the ups and downs of cannabis volatility